Lenalidomide-induced acute liver failure.
Jain
Pankaj
P
D000225:Adenine / Q000008:administration & dosage / Q000031:analogs & derivatives; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D000998:Antiviral Agents / Q000008:administration & dosage; D019694:Hepatitis B, Chronic / Q000097:blood / Q000150:complications / Q000188:drug therapy; D006801:Humans; D000077269:Lenalidomide; D017114:Liver Failure, Acute / Q000097:blood / Q000139:chemically induced*; D008297:Male; D009190:Myelodysplastic Syndromes / Q000097:blood / Q000150:complications / Q000188:drug therapy* / Q000235:genetics* / Q000628:therapy; D063065:Organophosphonates / Q000008:administration & dosage; D013792:Thalidomide / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*
D000970:Antineoplastic Agents; D000998:Antiviral Agents; D063065:Organophosphonates; D013792:Thalidomide; C053001:adefovir; D000077269:Lenalidomide; D000225:Adenine